-
Transcriptomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001509
-
2014 chunnam AML analysis
Study
EGAS00001001082
-
Finding structural variation from the human skin fibroblast at the single-cell level
Study
EGAS00001006498
-
An integrated molecular study of 20 hepatoblastoma pairs using whole genome sequencing and RNA sequencing
Study
EGAS00001002772
-
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Study
phs002486
-
Detecting and Subtyping Lung Cancer Through Analysis of Circulating Tumor DNA
Study
phs003570
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
Temporal Evolution Reveals Bifurcated Lineages in Aggressive Neuroendocrine Small Cell Prostate Cancer Trans-Differentiation
Study
phs003230
-
Genomic Landscape of Colorectal Cancer in a Multi-Ancestry Cohort
Study
phs003464
-
DynaTag for efficient profiling of transcription factors in small samples and single cells
Study
EGAS50000001074
-
High-coverage whole-genome sequencing reveals structural variations in triple-negative breast cancer
Study
JGAS000095
-
RNA sequencing and Illumina 2.5M SNP array data collected from 675 commonly used human cancer cell lines.
Study
EGAS00001000610
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis
Study
EGAS00001001788
-
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (microarray)
Study
EGAS00001004755
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis -Part II
Study
EGAS00001003357
-
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Study
EGAS00001006598
-
Immune and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 trials
Study
EGAS00001007563
-
Biomarker Data from KATHERINE: A Phase III Study of Adjuvant Trastuzumab Emtansine versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
Study
EGAS00001006229
-
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
Study
EGAS00001004660
-
FFPE_normals_v2_gbm_wtsi_panel
Study
EGAS00001002124
-
Human_Developmental_Cell_Atlas_HDCA___WGS
Study
EGAS00001002929
-
Childhood_arthritis_DNA
Study
EGAS00001002652
-
Kidney_tumour_RNA
Study
EGAS00001002487
-
Cell-Free, Methylated DNA in Blood Samples Reveals Tissue-Specific, Cellular Damage from Radiation Treatment
Study
phs003290
-
University of Texas PDX Development and Trial Center Grant
Study
phs001980
-
Comprehensive Genomic Characterization of Translocation Renal Cell Carcinoma
Study
phs003008
-
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Study
EGAS50000000135
-
Whole genome sequencing with linked reads of pediatric glioblastoma samples
Study
EGAS00001003432
-
Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
Study
EGAS00001003964
-
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models: validation cohort
Study
EGAS00001006582
-
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (WGS)
Study
EGAS00001004756
-
Point-of-care monitoring of head and neck cancer treatment response and recurrence development using nanopore-based ctDNA consensus sequencing
Study
EGAS00001007090
-
V4_Colorectal_panel_test
Study
EGAS00001001807
-
Multiple_myeloma_precursor_genomics
Study
EGAS00001006312
-
Mutational_signatures_and_clonal_dynamics_in_normal_human_tissues
Study
EGAS00001002471
-
California Pacific Medical Center Research Breast Health Cohort
Study
phs000395
-
Genomic Resistance Patterns to Second Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castrate-Resistant Prostate Cancer
Study
phs001447
-
Contribution of systemic and somatic factors to clinical response and resistance in urothelial cancer: an exploratory multi-omic analysis
Study
phs001743
-
Characterization of Prostate Cancer Organoids
Study
phs001587
-
Radiation-Related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident
Study
phs001134
-
Sensitive urothelial cancer detection via high volume urine DNA analysis
Study
EGAS50000000630
-
Single-Cell Genomic Analysis of Gastrointestinal Cancer
Study
phs001818
-
plasma DNA LINE-1 targeted bisulfite sequencing: a new non-invasive multi-cancer detection marker
Study
EGAS50000000446
-
DNTR sequencing data of paediatric acute lymphoblastic leukemia
Study
EGAS50000001247
-
scRNAseq analysis of CD8 T cells infiltrating the bladder and tumor of 4 non-muscle-invasive bladder cancer patients, before and after BCG treatment.
Study
EGAS50000001384
-
Use_of_Deep_Sequencing_to_Dectect_Clonal_Mutations_In_Sun_Exposed_Skin_Epidermis
Study
EGAS00001000515
-
Inter and intra - tumor heterogeneity in Colorectal Cancer
Study
EGAS00001002150
-
Use_of_Deep_Sequencing_to_Dectect_Clonal_Mutations_In_Sun_Exposed_Skin_Epidermis_PART2
Study
EGAS00001000603
-
Combination Therapies for Personalised Cancer Medicine in 11-18
Study
EGAS00001002579
-
Exome array analysis of adverse reactions to fluoropyrimidine-based therapy for gastrointestinal cancer
Study
EGAS00001002763